1. Home
  2. MXL vs AMLX Comparison

MXL vs AMLX Comparison

Compare MXL & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MaxLinear Inc.

MXL

MaxLinear Inc.

HOLD

Current Price

$16.62

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Amylyx Pharmaceuticals Inc.

AMLX

Amylyx Pharmaceuticals Inc.

HOLD

Current Price

$13.85

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MXL
AMLX
Founded
2003
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2010
2022

Fundamental Metrics

Financial Performance
Metric
MXL
AMLX
Price
$16.62
$13.85
Analyst Decision
Buy
Strong Buy
Analyst Count
7
7
Target Price
$20.25
$17.43
AVG Volume (30 Days)
1.1M
1.5M
Earning Date
10-23-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$423,372,000.00
N/A
Revenue This Year
$30.59
N/A
Revenue Next Year
$18.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.53
N/A
52 Week Low
$8.35
$2.60
52 Week High
$25.73
$16.96

Technical Indicators

Market Signals
Indicator
MXL
AMLX
Relative Strength Index (RSI) 62.13 49.61
Support Level $15.18 $14.48
Resistance Level $16.00 $15.24
Average True Range (ATR) 0.78 0.91
MACD 0.36 0.06
Stochastic Oscillator 97.58 55.20

Price Performance

Historical Comparison
MXL
AMLX

About MXL MaxLinear Inc.

MaxLinear Inc is a provider of radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and for data center, metro, and long-haul fiber networks. The company's radio frequency receiver products capture and process digital and analog broadband signals to be decoded for various applications. Its product options include both radio frequency receivers and radio frequency receiver systems-on-chips. The company's products enable the distribution and display of broadband video and data content in a wide range of electronic devices.

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.

Share on Social Networks: